+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ablation Technologies - Global Strategic Business Report

  • PDF Icon

    Report

  • 436 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4804540
The global market for Ablation Technologies was valued at US$5.2 Billion in 2024 and is projected to reach US$9.1 Billion by 2030, growing at a CAGR of 9.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Ablation Technologies Market - Key Trends & Drivers Summarized

Ablation technologies encompass a range of minimally invasive procedures used to destroy abnormal tissue, such as tumors or heart arrhythmias, through various energy sources. These technologies include radiofrequency ablation (RFA), laser ablation, microwave ablation, cryoablation, and high-intensity focused ultrasound (HIFU). Ablation procedures are increasingly preferred over traditional surgical methods due to their precision, reduced recovery times, and lower risk of complications. They are commonly used in oncology for the treatment of liver, lung, kidney, and prostate cancers, as well as in cardiology for treating atrial fibrillation and other cardiac arrhythmias.

The adoption of ablation technologies has been significantly influenced by advancements in imaging and guidance systems, which enhance the accuracy and effectiveness of ablation procedures. Real-time imaging technologies, such as MRI and CT scans, allow for precise targeting of the treatment area, minimizing damage to surrounding healthy tissue. The growing prevalence of chronic diseases, particularly cancer and cardiovascular disorders, is driving the demand for effective and minimally invasive treatment options. Additionally, ongoing research and development are expanding the applications of ablation technologies to new therapeutic areas, including neurology and orthopedics, further broadening their clinical utility.

The growth in the ablation technologies market is driven by several factors. Firstly, the increasing prevalence of cancer and cardiovascular diseases is boosting demand for effective minimally invasive treatments. Secondly, advancements in imaging and guidance technologies are enhancing the precision and outcomes of ablation procedures. Thirdly, the continuous innovation in ablation devices, including the development of novel energy sources and delivery systems, is expanding the range of treatable conditions. Lastly, the growing preference for outpatient and ambulatory procedures, driven by the benefits of reduced recovery times and healthcare costs, is promoting the adoption of ablation technologies. These factors collectively contribute to the robust growth of the ablation technologies market.

Scope of the Study

The report analyzes the Ablation Technologies market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments:

Type (Radiofrequency Ablation, Laser / Light Ablation, Ultrasound Ablation, Electrical Ablation, Cryoablation, Other Types); Application (Cardiovascular Disease Treatment, Cancer Treatment, Ophthalmologic Treatment, Pain Management, Gynecological Treatment, Urological Treatment, Other Applications).

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Radiofrequency Ablation segment, which is expected to reach US$3.7 Billion by 2030 with a CAGR of a 10.5%. The Laser / Light Ablation segment is also set to grow at 9.3% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $2.0 Billion in 2024, and China, forecasted to grow at an impressive 13.0% CAGR to reach $768.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Laboratories, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG, AngioDynamics, Inc., Arthrex, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Ablation Technologies Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Ablation Technologies Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Ablation Technologies Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Some of the 79 major companies featured in this Ablation Technologies market report include:

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • AngioDynamics, Inc.
  • Arthrex, Inc.
  • AtriCure, Inc.
  • Apyx Medical Corporation
  • CardioFocus, Inc.
  • Acoustic Medsystems, Inc.
  • Alpinion Medical Systems Co., Ltd.
  • CathVision ApS
  • Ablatus Therapeutics
  • Acutus Medical, Inc.
  • Blueacre Technologoy
  • Adagio Medical

Table of Contents

I. METHODOLOGYMII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Competition
  • Ablation Technologies - Global Key Competitors Percentage Market Share in 2024 (E)
  • Ablation Technologies Competitor Market Share Scenario Worldwide (in %): 2020E
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Ablation Technologies: A Prelude
  • Key Application Markets
  • Primary End-Use Applications for Energy Based Ablation Devices in Specific Treatments
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Shift towards Minimally Invasive Surgeries Fuels Demand for Ablation Procedures
  • Minimally Invasive Catheter Ablation Continues to Gain Prominence in Cardiac Procedures
  • Increasing Incidence of Cancer Drives Demand for Ablation Devices
  • Global Cancer Prevalence Statistics - Opportunity Indicators
  • Global Breakdown of Total Number of Cancer Cases by Type: 2023
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Ablation Technology: An Innovative Approach to Address Liver tumors
  • Microwave Ablation: Rethinking Future of Cancer Treatment
  • Rising Prevalence of Cardiovascular Diseases and Related Mortality Rates Fuel Cardiac Surgical Volumes Drive Growth in the Cardiac Ablation Market
  • Leading Causes of Mortality in High Income Countries: 2023
  • Global Cardiology and Cardiac Surgery Market: Revenues in US$ Billion for the Years 2017, 2019, 2021 and 2023
  • Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • Annual Medical Cost of Cardiovascular Diseases (CVD) in the United States for Years 2020, 2025, 2030 and 2035 (In US$ Billion)
  • Rising Incident of AF Underpins Extended Uptake of Advanced Ablation Technologies
  • Incidence of Atrial Fibrillation Per Million Population in United States (in %): 2000-2023
  • Ranking of Factors for Incidence of Atrial Fibrillation
  • Innovative Technologies Assist in Enhancing AF Ablation Process
  • Advancements Promise Better Future for Catheter Ablation
  • New Cryoablation Systems with Potential to Improve Symptomatic AF Treatment
  • AF Ablation in Paroxysmal AF and Persistent AF Patients
  • Catheter Ablation for Arrhythmias to Attain New Heights with Pulsed-Field Ablation
  • New Research Indicates Potential Role of AI for Better Diagnosis of Atrial Fibrillation
  • Robotics to Uplift & Add New Functional Dimension to AF Ablation
  • Remote Navigation Options
  • Ablation Found to be Effective for AF Compared to Medications
  • Ablation Technology for Supra-venticular Tachycardia
  • Growing Significance of Cardiac Ablation for Cardiac Rhythm Management
  • MRI-Guided Cardiac Ablation Grows in Adoption Rate
  • Hybrid Ablation Procedure for Treatment of Atrial Fibrillation: Addressing the Limitations of Traditional Treatments
  • Technological Advancements Broaden Adoption of Cardiac Ablation Technology
  • New Product Launches Set Pace for Ablation Technology Market
  • RF Ablation Continues to Remain a Dominant Technology
  • Applicability of Cryogenic Energy based Ablation Devices Continues to Grow
  • Electrical Energy Based Devices Find New Applciations
  • High Intensity Focused Ultrasound Remains a Budding Technology
  • Microwave Ablation Undergoes Renewed Focus to Improve Patient Outcomes
  • Microwave Ablation & Potential in Cancer Treatment
  • Rise in Endometrial Ablation Procedures to Improve Growth
  • Advanced Surface Ablation Picks up in Ophthalmology
  • Increasing Application in Aesthetic Treatments Spurs Demand
  • Aging Population Spurs Demand for Ablation Devices
  • Aging Population Steps-Up The Burden on Healthcare: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • As Cardiovascular Disease Prevalence Increases at a Strong Rate in Developing Economies, Tremendous Potential Exists for Cardiac Ablation Market
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Radiofrequency Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Radiofrequency Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Radiofrequency Ablation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Laser / Light Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Laser / Light Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Laser / Light Ablation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Ultrasound Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Ultrasound Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Ultrasound Ablation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Electrical Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Electrical Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Electrical Ablation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Cryoablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Cryoablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Cryoablation by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Cardiovascular Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Cardiovascular Disease Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Cardiovascular Disease Treatment by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Cancer Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Cancer Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Cancer Treatment by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Ophthalmologic Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Ophthalmologic Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Ophthalmologic Treatment by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 30: World 15-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 31: World Recent Past, Current & Future Analysis for Gynecological Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 32: World Historic Review for Gynecological Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 33: World 15-Year Perspective for Gynecological Treatment by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 34: World Recent Past, Current & Future Analysis for Urological Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 35: World Historic Review for Urological Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 36: World 15-Year Perspective for Urological Treatment by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 37: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 38: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 39: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 40: World Ablation Technologies Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Ablation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Ablation Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Ablation Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCEGERMANYITALYUNITED KINGDOMSPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
AUSTRALIA
  • Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Ablation Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFICLATIN AMERICAMIDDLE EASTAFRICAIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • AngioDynamics, Inc.
  • Arthrex, Inc.
  • AtriCure, Inc.
  • Apyx Medical Corporation
  • CardioFocus, Inc.
  • Acoustic Medsystems, Inc.
  • Alpinion Medical Systems Co., Ltd.
  • CathVision ApS
  • Ablatus Therapeutics
  • Acutus Medical, Inc.
  • Blueacre Technologoy
  • Adagio Medical

Table Information